3-Isobutyl-1-methylxanthine inhibits sustained calcium current independently of cyclic AMP in neuronal and endocrine cells

SM Simasko and S Yan

Department of Physiology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo 14214.

The effect of the phosphodiesterase inhibitor 3-isobutyl-1- methylxanthine (IBMX) on the voltage-dependent calcium current was studied in the clonal pituitary cell line GH3 by whole-cell patch-clamp techniques. It was found that IBMX reversibly inhibited the sustained calcium current (Ki, 1.25 mM), whereas there was no effect on the transient current. IBMX increased the inactivation rate of the sustained current without altering the voltage of activation. Vasoactive intestinal peptide, an agent known to increase cAMP, was without effect on the calcium current. The effect of IBMX was not altered by pretreating the cells with pertussis toxin or by including either cAMP or protein kinase inhibitor in the intracellular solution. The order of potency for several xanthine derivatives was IBMX > theophylline > caffeine > xanthine. The effect of IBMX on calcium current was also observed in three additional neuronal and endocrine cell lines (PC12, SY5Y, and RINm5f). These results indicate that IBMX inhibits sustained voltage-dependent calcium current by a mechanism independent of alterations in cAMP levels.

Volume 44, Issue 3, pp. 622-627, 09/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. J. Sawyer and L. Muscatine Cellular mechanisms underlying temperature-induced bleaching in the tropical sea anemone Aiptasia pulchella J. Exp. Biol., March 12, 2002; 204(20): 3443 - 3456. [Abstract] [Full Text] [PDF]